Engel-Riedel, W., Lowe, J., Mattson, P., Richard Trout, J., Huhn, R. D., Gargano, M., . . . Schneller, F. (2018). A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer. J Immunother Cancer.
Stile di citazione ChicagoEngel-Riedel, Walburga, et al. "A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination With Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer." J Immunother Cancer 2018.
Citazione MLAEngel-Riedel, Walburga, et al. "A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination With Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer." J Immunother Cancer 2018.